Innova Captab Limited (BOM:544067)

India · Delayed Price · Currency is INR

973.80

+10.90 (1.13%)

At close: Jul 20, 2026

7.97% (1Y)

Market Cap	55.69B +8.0%
Revenue (ttm)	16.30B +31.1%
Net Income	1.41B +9.9%
EPS	24.63 +9.9%
Shares Out	n/a
PE Ratio	39.52
Forward PE	29.35
Dividend	2.00 (0.21%)
Ex-Dividend Date	Jan 30, 2026

Volume	2,802
Open	960.00
Previous Close	962.90
Day's Range	951.90 - 977.00
52-Week Range	608.25 - 1,033.00
Beta	n/a
Analysts	Strong Buy
Price Target	1,078.50 (+10.75%)
Earnings Date	Jul 24, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, ... [Read more]

Industry Pharmaceutical Preparations

Founded 2005

Employees 1,600

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544067

Full Company Profile

Financial Performance

In fiscal year 2026, Innova Captab's revenue was 16.30 billion, an increase of 31.06% compared to the previous year's 12.44 billion. Earnings were 1.41 billion, an increase of 9.87%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 544067 stock is "Strong Buy." The 12-month stock price target is ₹1,079, which is an increase of 10.75% from the latest price.

Price Target

₹1,079

(10.75% upside)

Analyst Consensus: Strong Buy

Stock Forecasts